TeraRecon Launches Updated Intuition 4.10 Cardiac MRI Software
The updated software reportedly provides access to more than 200 enhanced features including optimized hanging protocols with a cardiac MRI viewer and perfusion quantification analysis.
Offering a range of enhanced features to facilitate precision with cardiac magnetic resonance imaging (MRI), TeraRecon has launched an updated version of its software-as-a-service (SaaS) platform Intuition 4.10.
In addition to facilitating expedited measurements and reporting on cardiac MRI cases, the Intuition 4.10 software provides a dedicated cardiac MRI viewer with hanging protocols and over 200 enhanced features, according to TeraRecon.
The updated software-as-a-service (SaaS) platform Intuition 4.10 from TeraRecon reportedly offers more than 200 enhanced features for cardiac MRI assessment and workflow. (Images courtesy of Adobe Stock.)
The company added that features such as extracellular volume (ECV) mapping, 2D flow analysis and a new global strain analysis workflow provide significant quantification tools for cardiac MRI analysis.
"TeraRecon's Intuition 4.10 release includes significant new enhancements to cardiac MR workflows," noted Christopher Maroules, M.D., the chief of cardiothoracic imaging at the Naval Medical Center Portsmouth in Portsmouth, Va. “This release allows me to start standardizing my post-processing cardiac workflows onto a single, broad tool for imaging workflows. The versatility of the dedicated cardiac MR viewer and various cardiac MR workflows enable me to conduct my day-to-day cardiac MR analysis in a streamlined and consistent manner."
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
